1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea has been researched along with fluorouracil in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Franklin, HR; McVie, JG; Taal, BG; ten Bokkel Huinink, WW | 1 |
Boot, H; Gortzak, E; Taal, BG; Van den Hout, BM; Zoetmulder, FA | 1 |
Bibby, MC; Hill, SR | 1 |
Rodenhuis, S; Taal, BG; Ten Bokkel Huinink, WW | 2 |
Chaudry, IH; Graffner, HO; Milsom, JW; Singh, G | 1 |
Alderson, D; Denton, G; Grace, RH; Hardcastle, JD; Lauri, H; Mansi, JL; Nordle, O; Smyth, JF; Wählby, S; Yosef, HM | 1 |
2 trial(s) available for 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea and fluorouracil
Article | Year |
---|---|
Combination chemotherapy with tauromustine (TCNU), 5-fluorouracil and leucovorin in advanced colorectal carcinoma: a dose-finding study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Nitrosourea Compounds; Prognosis; Taurine | 1993 |
Two phase III trials of tauromustine (TCNU) in advanced colorectal cancer.
Topics: Aged; Antineoplastic Agents; Colorectal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Nitrosourea Compounds; Prognosis; Quality of Life; Regression Analysis; Survival Rate; Taurine; Treatment Failure | 1995 |
5 other study(ies) available for 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea and fluorouracil
Article | Year |
---|---|
5-Fluorouracil plus tauromustine in advanced colorectal cancer: unexpected negative results.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Nitrosourea Compounds; Taurine | 1990 |
Long-term survival in two cases of colorectal carcinoma following a new chemotherapy regimen and subsequent metastasectomy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Taurine | 1995 |
5-Fluorouracil causes alterations in the pharmacokinetic profile of tauromustine in NMRI mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blood Proteins; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Interactions; Fluorouracil; Male; Mice; Mice, Inbred Strains; Nitrosourea Compounds; Protein Binding; Taurine | 1994 |
Tauromustine (TCNU) combined with 5-fluorouracil and leucovorin in the treatment of advanced colon cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Nitrosourea Compounds; Taurine; Treatment Outcome | 1993 |
Tauromustine is more effective than conventional chemotherapy in the treatment of colonic tumors.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Colonic Neoplasms; Drug Therapy, Combination; Fluorouracil; Leucovorin; Male; Mice; Mice, Inbred BALB C; Nitrosourea Compounds; Taurine | 1993 |